Total study participants | 2906 |
Age (years), mean (SD) | 69.4 (14.3) |
Troponin I (ng/mL) | 1.95 (12.19) |
Troponin measurements (#) | 20 709 |
Race | |
White | 1961 (67.5) |
Black | 799 (27.5) |
Other | 146 (5.0) |
Sex | |
Male | 1282 (44.1) |
Female | 1624 (55.9) |
Urbanicity | |
Urban | 1337 (46.0) |
Rural | 1569 (54.0) |
Comorbidities | |
Type 2 diabetes | 1432 (49.3) |
Ischaemic heart disease | 2045 (70.4) |
Chronic obstructive pulmonary disease | 894 (30.8) |
Chronic kidney disease | 1246 (42.9) |
Emphysema | 301 (10.4) |
Hypertension | 2425 (83.4) |
Hyperlipedaemia | 2210 (76.0) |
Peripheral artery disease | 751 (25.8) |